[P03-3pm] 17. Biofunctional Chemistry, Biotechnology

[P03-3pm-25] Development of artificial nucleic acid aptamers targeting SARS-CoV-2 spike protein

^○Yuuya Kasahara^1,2, Yoko Senga¹, Keisuke Tanaka^1,2, Kenta Ishida¹, Yumiko Imai¹, Satoshi Obika^1,2 (1. NIBIOHN, 2. Grad. Sch. Pharma. Sci., Osaka Univ.)

[Lang.] Japanese

Keywords:Aptamer, Artificial nucleic acid, COVID-19, SARS-CoV-2, Spike protein